Related references
Note: Only part of the references are listed.Practical management of tyrosine kinase inhibitor-associated side effects in GIST
Heikki Joensuu et al.
CANCER TREATMENT REVIEWS (2011)
Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
E. Jabbour et al.
LEUKEMIA (2011)
Course of the Modified Rodnan Skin Thickness Score in Systemic Sclerosis Clinical Trials Analysis of Three Large Multicenter, Double-Blind, Randomized Controlled Trials
Sogol Amjadi et al.
ARTHRITIS AND RHEUMATISM (2009)
Treatment With Imatinib Prevents Fibrosis in Different Preclinical Models of Systemic Sclerosis and Induces Regression of Established Fibrosis
Alfiva Akhmetshina et al.
ARTHRITIS AND RHEUMATISM (2009)
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model
Minglun Li et al.
RADIATION ONCOLOGY (2009)
Imatinib as a novel therapeutic approach for fibrotic disorders
J. H. W. Distler et al.
RHEUMATOLOGY (2009)
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial-results from the Scleroderma Lung Study
Dinesh Khanna et al.
RHEUMATOLOGY (2009)
Partial inhibition of integrin alpha v beta 6 prevents pulmonary fibrosis without exacerbating inflammation
Gerald S. Horan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Role of PDGF in fibrotic diseases and systemic sclerosis
M. Trojanowska
RHEUMATOLOGY (2008)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
Thomas Krieg et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study
D. Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice
Y Aono et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
A Abdollahi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Share Paper
